公司动态、产品里程碑、学术发表与合作进展。Company updates, product milestones, publications, and partnerships.
两套升级系统正在研发：自成一体的乳腺 MR 导航系统（单头显同时充当术中传感器与 AR 显示，去除外部光学追踪硬件）与无标记、免手、全自动、学习驱动的肝脏 MR 导航系统（以学习式 RGB-D 特征检测替代触笔数字化，SAM 2 自动分割）。Two upgraded systems are under active development: a self-contained breast MR navigation system (a single headset serves as both intraoperative sensor and AR display, eliminating external optical-tracking hardware) and a markerless, hands-free, fully automatic, learning-based liver MR navigation system (learned RGB-D feature detection replaces stylus digitization, with SAM 2 auto-segmentation).
"ReSNA: A Robotic-Enabled Surgical Navigation Assistant for Breast-Conserving Surgery" 发表于 IEEE Robotics and Automation Letters（DOI 10.1109/LRA.2026.3710046）。首创"眼在手上"双视觉机器人平台，作为主动观察者自动采集术中乳腺表面并驱动非刚性配准。向博文为共同作者。"ReSNA: A Robotic-Enabled Surgical Navigation Assistant for Breast-Conserving Surgery" published in IEEE Robotics and Automation Letters (DOI 10.1109/LRA.2026.3710046). A first-of-its-kind "eyes-in-hand" dual-vision robotic platform that acts as an active observer, acquiring intraoperative breast surface data to drive non-rigid registration. Bowen Xiang co-author.
"Mixed Reality Surgical Navigation System for Liver Interventions with Comprehensive Validation using Subsurface Target Localization" 发表于 IEEE Transactions on Biomedical Engineering（DOI 10.1109/TBME.2026.3704934）。首次提出面向 MR 手术导航亚表面靶点定位精度的标准化验证协议，含软组织形变矫正与微波探针实时导航。向博文为第一作者。"Mixed Reality Surgical Navigation System for Liver Interventions with Comprehensive Validation using Subsurface Target Localization" published in IEEE Transactions on Biomedical Engineering (DOI 10.1109/TBME.2026.3704934). Establishes the first standardized protocol for validating subsurface targeting accuracy in MR surgical navigation, with soft-tissue deformation correction and live microwave-probe guidance. Bowen Xiang first author.
¥5,000 万 - ¥1 亿人民币 A 轮融资正式启动。资金用于产品定型、三类 NMPA 注册全流程、多中心临床试验拓展与核心团队扩展。对标 MediView XR 2025/10 $24M A 轮。¥50M-¥100M Series A officially launched. Funding for product finalization, NMPA Class III registration, multi-center clinical trials, and team expansion. Benchmarked against MediView XR's $24M Series A (Oct 2025).
"Self-Contained Surgical Navigation System in AR HMD" 由范德堡大学提交美国临时专利，向博文为发明人。专利转让/许可通道已与公司建立。"Self-Contained Surgical Navigation System in AR HMD" filed as US provisional by Vanderbilt, with Bowen Xiang as inventor. License pathway with the company established.
国家医保局发布《手术和治疗辅助操作类医疗服务价格项目立项指南（试行）》，首次将手术机器人按临床参与程度分为"导航 / 参与执行 / 精准执行"三档，导航类产品首次获得独立支付通道。湖南省率先落地。China's NHSA released the tiered surgical robot pricing policy, establishing three categories — Navigate / Assist / Execute. For the first time, surgical navigation products have an independent reimbursement channel. Hunan province led implementation.
"Comprehensive mixed reality surgical navigation system for liver surgery" 发表于 Journal of Medical Imaging 12(5):055001。创始人 Bowen Xiang 为通讯/第一作者。是 MR 肝脏导航领域的代表性工作。"Comprehensive mixed reality surgical navigation system for liver surgery" published in Journal of Medical Imaging 12(5):055001. Bowen Xiang as corresponding/first author — a definitive work in MR liver navigation.
"一种混合现实手术导航方法及系统"（CN 202510971966.8）经国家知识产权局初审通过，于 41 卷 4402 期专利公报公布。"A Mixed Reality Surgical Navigation Method and System" (CN 202510971966.8) passed initial CNIPA examination and was published in Vol 41, Issue 4402 of the patent gazette.
公司正式注册成立，可与国内 MR 头戴龙头灵伴科技建立深度合作，背靠国内 Spatial AI 产业生态。XiangshuTech Co., Ltd. officially registered, enabling deep collaboration with leading domestic MR vendor Rokid and tapping into China's emerging Spatial AI industrial ecosystem.
MR 肝脏手术导航整机系统在范德堡医学中心（VUMC）完成两阶段临床评估，验证系统在真实手术场景下的可用性与精度。The MR liver surgery navigation system completed two-phase clinical evaluation at Vanderbilt Medical Center (VUMC) — validating usability and accuracy in real surgical settings.
完整论文列表请访问 Google Scholar。Full publication list on Google Scholar.